A new imaging agent has been licensed by the Food and Drug Administration to identify Advanced Prostate Cancer after it has spread to other regions of the body. Experts believe the tracer, developed by Lantheus, will provide doctors with crucial visual help in guiding them to metastatic prostate cancer cells that have hitherto been difficult […]
Read More